Events - CRIION

Symposium
“Intelligent Oncology – The Potential of AI to Control Cancer“

MISSION

Bringing together experts from various disciplines to explore the latest advances in AI-assisted cancer research. Our goal is to promote collaboration between researchers, physicians, industry leaders, and other visionaries in the field. By sharing knowledge and expertise, we aim to discover new ways to control cancer through the power of AI.

–

AIM OF THE CONFERENCE

The theme of the conference is Intelligent Oncology, focusing on harnessing the power of AI to control cancer. Our aim is to present cutting-edge research and innovative approaches in cancer diagnosis, prognosis, and treatment. We aim to identify new research directions, foster collaborations between academia and industry, and facilitate the translation of research findings into clinical practice. By connecting experts in the field, we aim to accelerate progress towards more effective and personalized cancer treatment.

–

AREAS OF FOCUS

AI in cancer diagnosis/treatment

Computational methods for cancer research

Precision medicine with AI

Ethical, regulatory and governance issues of AI for health

Clinical translation of AI health interventions

Innovative AI technologies/platforms

Interdisciplinary collaborations in cancer

–

SCIENTIFIC BOARD

Prof. Dr. Mascha Binder
CRIION Scientific Director Clinical Oncology & University Hospital Basel

Prof. Dr. Joschka Boedecker
CRIION Scientific Director AI & Department of Computer Science, University of Freiburg

Prof. Dr. Dr. Melanie Börries
CRIION Scientific Director Systems Medicine & Medical Center, University of Freiburg

Prof. Dr. Robert Zeiser
CRIION Scientific Director Translational Oncology & Medical Center, University of Freiburg

Prof. em. Dr. Dr. h.c. mult. Roland Mertelsmann
CEO Mertelsmann Foundation & Medical Center, University of Freiburg

Dr. Maria Kalweit
CRIION Head of Applied AI Research & Department of Computer Science, University of Freiburg

Dr. Gabriel Kalweit
CRIION Head of Fundamental AI Research & Department of Computer Science, University of Freiburg

–

PRELIMINARY PROGRAM 2024

Session 1: Understanding Cancer Through AI and Computational Biology
This session will explore how AI and computational biology can improve our understanding of cancer.

Session 2: Translating AI and Computational Biology into Clinical Applications
In this session, speakers will discuss the challenges and opportunities of translating AI and computational biology into clinical practice for cancer diagnosis, prognosis, and treatment.

Session 3: Ethical, Regulatory and Governance Considerations
This session will examine ethical, regulatory and governance issues related to the development and deployment of AI and computational biology-powered cancer therapies.